Apple Set to Abandon Lightning Connector for iPhone 15

1 Mins read

Apple is reportedly poised to replace its unique Lightning connector with a more universal standard, the USB-C connector, in its upcoming iPhone 15. This move comes in response to regulations set forth by the European Union.

Recently leaked images circulating on social media indicate that the internal components of the iPhone 15 will feature USB-C ports instead of Apple’s proprietary Lightning ports.

Apple has yet to respond to a request for comment regarding this development.

In the past year, Apple announced its intention to adhere to EU regulations, which require electronic devices sold within the 27-nation bloc to include USB-C ports by 2024. However, Apple has not provided specific details on its compliance strategy.

While the EU argues that this rule will reduce electronic waste, Apple believes it will hinder innovation and create a larger waste problem. With over a billion iPhone users worldwide, many will be left with Lightning cables that are incompatible with the latest iPhone model. Notably, Apple already incorporates USB-C connectors in some of its iPads and laptops.

The success of the iPhone 15 is crucial for Apple, as its stock has faced declines following its recent earnings report. Bloomberg reports that the new smartphone is slated to be released on September 22.

According to analysts at Melius Research, the iPhone 15 is expected to have significant upgrades, such as faster processors, support for USB-C charging, expanded Dynamic Island support, and a sleeker design.

As of Wednesday, Apple’s shares had dropped by 0.9% to $178.20.

Related posts

Your Social Security Checks are Safe

2 Mins read
Don’t worry, the impending federal government shutdown will not put your monthly Social Security checks in jeopardy. This is certainly a relief…

European Stocks Experience Decrease

1 Mins read
The European stock market saw a decline on Friday, with the Stoxx Europe 600 index finishing down 0.31% at 453.26. Individual Index…

Positive Results for Cancer-Drug Combination in Bladder Cancer Study

1 Mins read
A recent Phase 3 study conducted by Merck & Co., Seagen, and Astellas Pharma has achieved its primary goals in certain patients…

Leave a Reply

Your email address will not be published. Required fields are marked *